| Remsima 40 mg/mL concentrate for solution for infusion EU/1/13/853/018-027 |
Infliximab |
Celltrion Healthcare Hungary Kft. |
— |
| Renagel EU/1/99/123/006 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/007 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/009 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/010 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel EU/1/99/123/011-013 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel 400 mg Film-coated tablet EU/1/99/123/005-007 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Renagel 800 mg Film-coated tablet EU/1/99/123/008-013 |
Sevelamer |
Sanofi Winthrop Industrie |
— |
| Rennie 750 mg Medicated Chewing Gum PA1410/089/001 |
Calcium carbonate |
Bayer Limited |
Marketed |
| Rennie Deflatine Chewable Tablets Calcium Carbonate 680mg Magnesium Carbonate 80mg Simeticone 25mg PA1410/051/001 |
Calcium carbonate, Magnesium carbonate, Simeticone |
Bayer Limited |
Marketed |
| Rennie Dual Action Chewable Tablets Calcium carbonate 625mg Magnesium carbonate 73.5mg Alginic acid 150mg PA1410/052/003 |
Alginic acid, Calcium carbonate, Magnesium carbonate |
Bayer Limited |
Not marketed |
| Rennie Orange 500mg Chewable Tablets PA1410/054/001 |
Calcium carbonate |
Bayer Limited |
Marketed |
| Rennie Peppermint 680mg/80mg Chewable Tablets PA1410/053/001 |
Calcium carbonate, Magnesium carbonate |
Bayer Limited |
Marketed |
| Rennie Spearmint 680mg/80mg Chewable tablets PA1410/053/002 |
Calcium carbonate, Magnesium carbonate |
Bayer Limited |
Marketed |
| Rennie Sugar Free 680 mg/80 mg Chewable tablets PA1410/053/003 |
Magnesium carbonate, Calcium carbonate |
Bayer Limited |
Marketed |
| RENOCIS 1 mg kit for radiopharmaceutical preparation PA0677/005/001 |
Succimer |
CIS bio International |
Marketed |
| Renvela 0.8 g Powder for oral suspension EU/1/09/521/008-009 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 0.8 g Powder for oral suspension (with dosing spoon) EU/1/09/521/009 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 1.6 g Powder for oral suspension EU/1/09/521/4-5 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 2.4 g Powder for oral suspension EU/1/09/521/6-7 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Renvela 800 mg Film-coated tablet EU/1/09/521/1-3 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Repaglinide Accord 0.5 mg tablets EU/1/11/743/001-005 |
Repaglinide |
Accord Healthcare S.L.U. |
— |
| Repaglinide Accord 1 mg tablets EU/1/11/743/006-010 |
Repaglinide |
Accord Healthcare S.L.U. |
— |
| Repaglinide Accord 2 mg tablets EU/1/11/743/011-015 |
Repaglinide |
Accord Healthcare S.L.U. |
— |
| Repaglinide Krka 0.5 mg tablets EU/1/09/579/1-6 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Krka 1 mg tablets EU/1/09/579/7-12 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Krka 2 mg tablets EU/1/09/579/13-18 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Teva 0.5 mg Tablet EU/1/09/530/1-5 |
Repaglinide |
Teva Pharma B.V. |
— |
| Repaglinide Teva 1 mg Tablet EU/1/09/530/6-10 |
Repaglinide |
Teva Pharma B.V. |
— |
| Repaglinide Teva 2 mg Tablet EU/1/09/530/11-15 |
Repaglinide |
Teva Pharma B.V. |
— |
| Repatha 140 mg solution for injection in pre-filled pen EU/1/15/1016/002-005 |
Evolocumab |
Amgen Europe B.V. |
— |
| Repatha 140 mg solution for injection in pre-filled syringe EU/1/15/1016/001 |
Evolocumab |
Amgen Europe B.V., |
— |
| Repatha 420 mg solution for injection in cartridge EU/1/15/1016/006-007 |
Evolocumab |
Amgen Europe B.V. |
— |
| REPEVAX, suspension for injection, in pre-filled syringe Diphtheria, Tetanus, Pertussis (acellular, component) and Poliomyelitis (inactivated) Vaccine (adsorbed, reduced antigen(s) content) PA23458/004/001 |
Tetanus toxoid, Diphtheria toxoid, Pertussis toxoid, Filamentous haemagglutinin, Pertactin |
Sanofi Winthrop Industrie |
Not marketed |
| Replagal 1 mg/ml concentrate for solution for infusion EU/1/01/189/001 |
Agalsidase alfa |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Repso EU/1/11/674/006-010 |
Leflunomide |
Teva Pharma B.V. |
— |
| Requip 0.25 mg film-coated tablets PA1077/037/001 |
Ropinirole |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Requip 1 mg film-coated tablets PA1077/037/003 |
Ropinirole |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Requip 2 mg film-coated tablets PA1077/037/004 |
Ropinirole |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Requip 5 mg film-coated tablets PA1077/037/005 |
Ropinirole |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Requip-Modutab 2 mg Prolonged-Release Tablets PA1077/037/006 |
Ropinirole hydrochloride |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Requip-Modutab 2 mg Prolonged-Release Tablets PPA0465/279/002 |
Ropinirole hydrochloride |
PCO Manufacturing Ltd. |
— |
| Requip-Modutab 2 mg Prolonged-Release Tablets PPA1463/163/001 |
Ropinirole |
IMED Healthcare Ltd., |
— |
| Requip-Modutab 4 mg prolonged-release tablets PPA2306/002/002 |
Ropinirole |
Originalis B.V. |
— |
| Requip-Modutab 4 mg Prolonged-Release Tablets PA1077/037/008 |
Ropinirole hydrochloride |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Requip-Modutab 4 mg Prolonged-Release Tablets PPA0465/279/003 |
Ropinirole hydrochloride |
PCO Manufacturing Ltd. |
— |
| Requip-Modutab 4 mg Prolonged-Release Tablets PPA1463/163/002 |
Ropinirole |
IMED Healthcare Ltd., |
— |
| Requip-Modutab 8 mg prolonged-release tablets PPA2306/002/001 |
Ropinirole |
Originalis B.V. |
— |
| Requip-Modutab 8 mg Prolonged-Release Tablets PA1077/037/009 |
Ropinirole hydrochloride |
GlaxoSmithKline (Ireland) Limited |
Not marketed |
| Requip-Modutab 8 mg Prolonged-Release Tablets PPA1463/163/003 |
Ropinirole |
IMED Healthcare Ltd., |
— |